Skip to content
Sign in
StableHealthReported 2026-11-09 23:56

FDA warns GLP-1 drugs may cause rare eye condition

The FDA has warned that GLP-1 drugs, used for weight loss, may carry a risk of a rare eye condition called NAION, which can lead to sudden vision loss and blindness.

Why it matters. Patients and doctors using GLP-1 drugs will need to be aware of this potential risk, which could affect millions of people using these medications.

01

Evidence

  • SSTATMedia2026-11-09 23:56
    View source
  • BBBC WorldMedia2026-11-11 02:43
    View source
  • MMedical XpressMedia2026-11-11 06:00
    View source